Jundishapur Journal of Microbiology

Published by: Kowsar

Effect of Propranolol Alone and in Combination with Pyrimethamine on Acute Murine Toxoplasmosis

Mahbobeh Montazeri 1 , 2 , Ahmad Daryani 1 , 2 , * , Mohammadali Ebrahimzadeh 3 , Ehsan Ahmadpour 4 , Mehdi Sharif 1 , 2 and Shahabeddin Sarvi 1 , 2
Authors Information
1 Toxoplasmosis Research Center, Mazandaran University of Medical Sciences, Sari, IR Iran
2 Department of Parasitology and Mycology, Sari Medical School, Mazandaran University of Medical Sciences, Sari, IR Iran
3 Pharmaceutical Sciences Research Center, School of Pharmacy, Mazandaran University of Medical Sciences Sari, IR Iran
4 Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, IR Iran
Article information
  • Jundishapur Journal of Microbiology: September 01, 2015, 8 (9); e22572
  • Published Online: September 7, 2015
  • Article Type: Research Article
  • Received: August 6, 2014
  • Revised: December 3, 2014
  • Accepted: January 26, 2015
  • DOI: 10.5812/jjm.22572

To Cite: Montazeri M, Daryani A, Ebrahimzadeh M, Ahmadpour E, Sharif M, et al. Effect of Propranolol Alone and in Combination with Pyrimethamine on Acute Murine Toxoplasmosis, Jundishapur J Microbiol. 2015 ; 8(9):e22572. doi: 10.5812/jjm.22572.

Abstract
Copyright © 2015, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Footnotes
References
  • 1. Petersen E. Toxoplasmosis. Semin Fetal Neonatal Med. 2007; 12(3): 214-23[DOI][PubMed]
  • 2. Weiss LM, Dubey JP. Toxoplasmosis: A history of clinical observations. Int J Parasitol. 2009; 39(8): 895-901[DOI][PubMed]
  • 3. Weiss LM, Kim K. Toxoplasma gondii: the model apicomplexan. Perspectives and methods. 2011;
  • 4. Ambroise-Thomas P, Pelloux H. Toxoplasmosis - congenital and in immunocompromised patients: a parallel. Parasitol Today. 1993; 9(2): 61-3[PubMed]
  • 5. Serranti D, Buonsenso D, Valentini P. [Congenital toxoplasmosis treatment]. Eur Rev Med Pharmacol Sci. 2011; 15(2): 193-8[PubMed]
  • 6. Al-Zanbagi NA. Effectiveness of Myrrh and Spiramycin as Inhibitors for Toxoplasma gondii Tachyzoites in vivo. Mansoura J Forensic Med Clin Toxicol. 2007; 15(2): 117-28
  • 7. Araujo FG, Remington JS. Recent advances in the search for new drugs for treatment of toxoplasmosis. Int J Antimicrob Agents. 1992; 1(4): 153-64[PubMed]
  • 8. Ryning FW, Remington JS. Effect of cytochalasin D on Toxoplasma gondii cell entry. Infect Immun. 1978; 20(3): 739-43[PubMed]
  • 9. Morisaki JH, Heuser JE, Sibley LD. Invasion of Toxoplasma gondii occurs by active penetration of the host cell. J Cell Sci. 1995; 108 ( Pt 6): 2457-64[PubMed]
  • 10. D'Angelo JG, Bordon C, Posner GH, Yolken R, Jones-Brando L. Artemisinin derivatives inhibit Toxoplasma gondii in vitro at multiple steps in the lytic cycle. J Antimicrob Chemother. 2009; 63(1): 146-50[DOI][PubMed]
  • 11. Daryani A, Ebrahimzadeh MA, Sharif M, Rezaei F, Ahmadpour E, Sarvi S. The inhibitory effect of ketotifen on entrance of Toxoplasma gondii tachyzoites into macrophages of mouse. J Mazandaran Univ Med Sci. 2014; 23(110): 75-80
  • 12. Daryani A, Hosseini AZ, Dalimi A. Immune responses against excreted/secreted antigens of Toxoplasma gondii tachyzoites in the murine model. Vet Parasitol. 2003; 113(2): 123-34[PubMed]
  • 13. Yang CD, Chang GN, Chao D. Protective immunity against Toxoplasma gondii in mice induced by the SAG2 internal image of anti-idiotype antibody. Parasitol Res. 2003; 91(6): 452-7[DOI][PubMed]
  • 14. Dadimoghaddam Y, Daryani A, Sharif M, Ahmadpour E, Hossienikhah Z. Tissue tropism and parasite burden of Toxoplasma gondii RH strain in experimentally infected mice. Asian Pac J Trop Med. 2014; 7(7): 521-4[DOI][PubMed]
  • 15. Langslet A. Membrane stabilization and cardiac effects of d,1-propranolol, d-propranolol and chlorpromazine. Eur J Pharmacol. 1970; 13(1): 6-14[PubMed]
  • 16. Martins-Duarte ES, de Souza W, Vommaro RC. Toxoplasma gondii: the effect of fluconazole combined with sulfadiazine and pyrimethamine against acute toxoplasmosis in murine model. Exp Parasitol. 2013; 133(3): 294-9[DOI][PubMed]
  • 17. Fung HB, Kirschenbaum HL. Treatment regimens for patients with toxoplasmic encephalitis. Clin Ther. 1996; 18(6): 1037-56[PubMed]
  • 18. Foppa CU, Bini T, Gregis G, Lazzarin A, Esposito R, Moroni M. A retrospective study of primary and maintenance therapy of toxoplasmic encephalitis with oral clindamycin and pyrimethamine. Eur J Clin Microbiol Infect Dis. 1991; 10(3): 187-9[PubMed]
  • 19. Ohnishi ST, Sadanaga KK, Katsuoka M, Weidanz WP. Effects of membrane acting-drugs on plasmodium species and sickle cell erythrocytes. Mol Cell Biochem. 1989; 91(1-2): 159-65[PubMed]
  • 20. Singh N, Puri SK. Interaction between chloroquine and diverse pharmacological agents in chloroquine resistant Plasmodium yoelii nigeriensis. Acta Trop. 2000; 77(2): 185-93[PubMed]
  • 21. Murphy SC, Harrison T, Hamm HE, Lomasney JW, Mohandas N, Haldar K. Erythrocyte G protein as a novel target for malarial chemotherapy. PLoS Med. 2006; 3(12)[DOI][PubMed]
  • 22. Manninen V. Movements of sodium and potassium ions and their tracers in propranolol-treated red cells and diaphragm muscle. Acta Physiol Scand Suppl. 1970; 355: 1-76[PubMed]
  • 23. Porter RS, Kaplan JL. The Merck manual of diagnosis and therapy.
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments